Reaction
Bronchial Neoplasm reporting signals
As of the last recalculation, Bronchial Neoplasm appears in 135 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 898.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 50 | 898.3 | 901.6 |
| Theophylline Anhydrous | 46 | 867.2 | 870.4 |
| Theophylline | 40 | 762.0 | 764.7 |
| Fluticasone Furoate | 25 | 390.3 | 391.1 |
| Esomeprazole Magnesium Capsule, Delayed Release | 27 | 358.4 | 359.0 |
| Esomeprazole Magnesium Delayed Release Capsules | 27 | 358.4 | 359.0 |
| Esomeprazole Magnesium Dihydrate | 27 | 356.8 | 357.5 |
| Ipratropium Bromide | 50 | 342.6 | 343.1 |
| Valsartan Oral | 50 | 224.8 | 225.0 |
| Valsartan And Hydrochlorothiazide | 16 | 206.0 | 206.2 |
| Cetirizine Hydrochloride Allergy | 30 | 196.1 | 196.3 |
| Cetirizine Hydrochloride Tablets | 30 | 196.1 | 196.2 |
| Duloxetine | 46 | 153.9 | 154.0 |
| Fluticasone Propionate And Salmeterol Xinafoate | 40 | 145.5 | 145.6 |
| Conjugated Estrogens | 33 | 115.2 | 115.3 |
| Estrogens, Conjugated | 33 | 113.1 | 113.2 |